Psychiatry A
MADRS — Montgomery-Åsberg Depression Scale
10-item clinician-rated scale for measuring severity of depression episodes. Commonly used in clinical trials.
Used in: Depression & Anxiety
Score interpretation
No/Symptom Absent 0–6
Score 0–6: No or very mild depression
→ No specific treatment indicated
Mild Depression 7–19
Score 7–19: Mild depression
→ Watchful waiting; psychological intervention
Moderate Depression 20–34
Score 20–34: Moderate depression
→ Antidepressant therapy and/or psychotherapy
Severe Depression 35–60
Score ≥35: Severe depression
→ Active pharmacotherapy; consider ECT; assess suicide risk urgently
Interpretation bands for the MADRS. Apply clinical judgement and local guidance.
References
- Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Lissamine Green 1% Eye Drops · Vital Dye — Ocular Surface Staining (Dry Eye Diagnosis)
- Lamotrigine (Psychiatric Use) · Mood Stabiliser (Sodium Channel Blocker) — Bipolar Depression
- Esketamine · NMDA Receptor Antagonist (Treatment-Resistant Depression / Acute Suicidality)
- Lumateperone · Atypical Antipsychotic — Multimodal (Schizophrenia / Bipolar Depression)
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.